These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 13108954)

  • 1. The physiologic activity of l-triiodothyronine.
    LERMAN J
    J Clin Endocrinol Metab; 1953 Nov; 13(11):1341-6. PubMed ID: 13108954
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic activity of desiccated thyroid substance, sodium L-thyroxine and D, L-triiodothyronine; a comparative study.
    MCGAVACK TH; RECKENDORF HK
    Am J Med; 1956 May; 20(5):774-7. PubMed ID: 13313575
    [No Abstract]   [Full Text] [Related]  

  • 3. [L-3,5,3' -triiodothyronine, L-thyroxin and treatment of myxedema; new experiments in the treatment of myxedema by oral triiodothyronine].
    BARAC G
    Rev Med Liege; 1957 Apr; 12(7):173-8. PubMed ID: 13432405
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic and therapeutic effects of triiodothyronine.
    FRAWLEY TF; MCCLINTOCK JC; BEEBE RT; MARTHY GL
    J Am Med Assoc; 1956 Feb; 160(8):646-52. PubMed ID: 13286110
    [No Abstract]   [Full Text] [Related]  

  • 5. MAGNESIUM balance in myxedematous patients treated with triiodothyronine.
    Nutr Rev; 1956 Jan; 14(1):6-7. PubMed ID: 13280191
    [No Abstract]   [Full Text] [Related]  

  • 6. Triiodothyronine in myxedema and familial sporadic cretinism with goiter.
    ZONDEK H; LESZYNSKY HE; ZONDEK GW
    Acta Endocrinol (Copenh); 1955 Feb; 18(2):117-32. PubMed ID: 14349556
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of the metabolic activities of 3,5,3-L-triiodothyronine and L-thyroxine in myxedema.
    ASPER SP; SELENKOW HA; PLAMONDON CA
    Bull Johns Hopkins Hosp; 1953 Sep; 93(3):164-98. PubMed ID: 13094265
    [No Abstract]   [Full Text] [Related]  

  • 8. The effectiveness of triiodothyronine or thyroxine administered orally in the treatment of myxedema.
    SELENKOW HA; ASPER SP
    J Clin Endocrinol Metab; 1955 Mar; 15(3):285-96. PubMed ID: 14353993
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of triiodothyronine & thyroxin in primary myxedema; comparative investigation].
    FRIIS T; IVERSEN K
    Ugeskr Laeger; 1957 Nov; 119(48):1548-51. PubMed ID: 13530302
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of L-3,5,3'-triiodothyronine in a case of congenital myxedema].
    DELTOUR G; BEKAERT J
    Ann Endocrinol (Paris); 1953; 14(1):87-91. PubMed ID: 13092596
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolic effects of thyroxine analogues in human myxedema.
    BENUA RS; LEEPER RD; KUMAOKA S; RAWSON RW
    Ann N Y Acad Sci; 1960 Apr; 86():563-81. PubMed ID: 13799050
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of 3:5:3'-tribromo-DL-thyronine in myxoedema.
    COMPSTON N; PITT-RIVERS R
    Lancet; 1956 Jan; 270(6906):22-3. PubMed ID: 13279155
    [No Abstract]   [Full Text] [Related]  

  • 13. Magnesium balance in myxedematous patients treated with triiodothyronine: preliminary note.
    TAPLEY DF
    Bull Johns Hopkins Hosp; 1955 Jun; 96(6):274-8. PubMed ID: 14378809
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolic activity of the d-isomers of thyroxine and tri-iodothyronine.
    BEST MM; DUNCAN CH
    N Engl J Med; 1962 Sep; 267():475-9. PubMed ID: 13868587
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment for congenital myxedema by DL-3,5,3'-triiodothyronine].
    LELONG M; JOSEPH R; CANLORBE P; DELTOUR G; BORNICHE P; SCHOLLER R
    Sem Hop; 1956 May; 32(31/5):1777-80. PubMed ID: 13351681
    [No Abstract]   [Full Text] [Related]  

  • 16. A study of the rate of protein synthesis before and during the administration of L-triiodothyronine to patients with myxedema and healthy volunteers using N-15 glycine.
    CRISPELL KR; PARSON W; HOLLIFIELD G
    J Clin Invest; 1956 Feb; 35(2):164-9. PubMed ID: 13286335
    [No Abstract]   [Full Text] [Related]  

  • 17. [L-thyroxin sodium in therapy of myxedema].
    LUND E
    Nord Med; 1954 Jun; 51(26):880-1. PubMed ID: 13176763
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral sodium L-thyroxine in the treatment of myxedema and cretinism.
    SALTER WT; ROSENBLUM I
    Am J Med Sci; 1952 Dec; 224(6):628-31. PubMed ID: 12996505
    [No Abstract]   [Full Text] [Related]  

  • 19. [Congenital hypothyroidism & myxedema, treated with triiodothyronine, with special reference to the ECG].
    LANGANKE E
    Munch Med Wochenschr; 1957 Mar; 99(13):454-5. PubMed ID: 13430688
    [No Abstract]   [Full Text] [Related]  

  • 20. 17-Ketosteroid and pituitary follicle-stimulating hormone excretion in myxedema, before and during treatment with thyroxine.
    BEIERWALTES WH; BISHOP RC
    J Clin Endocrinol Metab; 1954 Aug; 14(8):928-38. PubMed ID: 13183986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.